Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey

by | Jul 1, 2021

Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey

Mahil, S. K., Yates, M., Langan, S. M., Yiu, Z. Z. N., Tsakok, T., Dand, N., Mason, K. J., Mcateer, H., Meynell, F., Coker, B., Vincent, A., Urmston, D., Vesty, A., Kelly, J., Lancelot, C., Moorhead, L., Bachelez, H., Bruce, I. N., Capon, F. & Contreras, C. R. & 23 others, Cope, A. P., De la cruz, C., Di Meglio, P., Gisondi, P., Hyrich, K., Jullien, D., Lambert, J., Marzo‐ortega, H., Mcinnes, I., Naldi, L., Norton, S., Puig, L., Sengupta, R., Spuls, P., Torres, T., Warren, R. B., Waweru, H., Weinman, J., Griffiths, C. E. M., Barker, J. N., Brown, M. A., Galloway, J. B. & Smith, C. H., 1 Jul 2021, In: British Journal of Dermatology. 185, 1, p. 80-90

Research output: Contribution to journal › Article › peer-review